方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 炎症性肠病简明问卷× | Harvey-Bradshaw指数× | |
|---|---|---|
| 领域 | 胃肠病学 | 胃肠病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2004 | 1980 |
| 提出者≠ | Guyonnet, D., Chassany, O., Ducroc, R., et al. | R. F. Harvey and J. M. Bradshaw |
| 类型≠ | Self-report | Clinician-rated |
| 开创性文献≠ | Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| 别名≠ | IBDQ-32, Short IBDQ | HBI |
| 相关≠ | 4 | 5 |
| 摘要≠ | The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGate数据集 ↗ |
|
|